$260.77
4.291.67%
Last update: Oct 9, 12:29 PM
$255.04
-1.44-0.56%
Johnson & Johnson
JNJNYSE
Johnson & Johnson (JNJ) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Johnson & Johnson (JNJ) last issued guidance on July 15, 2026 for fiscal year 2026. The company guided earnings per share in the range of $11.6 - $11.75, compared to a consensus EPS estimate of $11.57. Johnson & Johnson also guided revenue in the range of $100.8B - $101.4B for the period.
Compared to prior guidance, Johnson & Johnson raised its EPS outlook from a previous range of $11.45 - $11.65. On the revenue side, the company maintained its revenue forecast from a prior range of $100.3B - $101.3B.
Johnson & Johnson has issued 19 guidance updates between October 18, 2022 and July 15, 2026. During this period, the company raised its outlook 6 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.85 | $2.67 | $2.47 | $2.76 |
| Actual | $2.90 | $2.70 | $2.46 | $2.80 |
| Surprise | +1.75% | +1.12% | -0.40% | +1.45% |
| Revenue | ||||
| Estimate | $25.05B | $23.54B | $24.15B | $23.75B |
| Actual | $25.31B | $24.06B | $24.56B | $23.99B |
| Surprise | +1.04% | +2.20% | +1.71% | +1.03% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.59 | $2.94 | $2.96 | $3.21 |
| Revenue | ||||
| Consensus | $25.37B | $26.46B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $2.90 | $2.85 | 1.75 % |
| Q1 | Apr 14, 2026 | $2.70 | $2.67 | 1.12 % |
| Q4 | Jan 21, 2026 | $2.46 | $2.47 | -0.40 % |
| Q3 | Oct 14, 2025 | $2.80 | $2.76 | 1.45 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $25.31B | $25.05B | 1.04 % |
| Q1 | Apr 14, 2026 | $24.06B | $23.54B | 2.20 % |
| Q4 | Jan 21, 2026 | $24.56B | $24.15B | 1.71 % |
| Q3 | Oct 14, 2025 | $23.99B | $23.75B | 1.03 % |
